Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Accelerated partial breast irradiation in a single 18 Gy fraction with high-dose-rate brachytherapy: preliminary results.
Latorre JA, Galdós P, Buznego LA, Blanco AG, Cardenal J, Ferri M, de Cerio ID, Arrojo E, Sierrasesúmaga N, Noriega MG, Ferré AJ, Fabregat R, Ruíz S, Prada PJ. Latorre JA, et al. Among authors: blanco ag. J Contemp Brachytherapy. 2018 Feb;10(1):58-63. doi: 10.5114/jcb.2018.73994. Epub 2018 Feb 28. J Contemp Brachytherapy. 2018. PMID: 29619057 Free PMC article.
High-dose-rate interstitial brachytherapy as monotherapy in one fraction of 20.5 Gy for the treatment of localized prostate cancer: Toxicity and 6-year biochemical results.
Prada PJ, Ferri M, Cardenal J, Blanco AG, Anchuelo J, Díaz de Cerio I, Vázquez A, Pacheco M, Raba I, Ruiz S. Prada PJ, et al. Among authors: blanco ag. Brachytherapy. 2018 Nov-Dec;17(6):845-851. doi: 10.1016/j.brachy.2018.06.002. Epub 2018 Jul 18. Brachytherapy. 2018. PMID: 30030111
High-dose-rate interstitial brachytherapy as monotherapy in one fraction for the treatment of favorable stage prostate cancer: Toxicity and long-term biochemical results.
Prada PJ, Cardenal J, Blanco AG, Anchuelo J, Ferri M, Fernández G, Arrojo E, Vázquez A, Pacheco M, Fernández J. Prada PJ, et al. Among authors: blanco ag. Radiother Oncol. 2016 Jun;119(3):411-6. doi: 10.1016/j.radonc.2016.04.006. Epub 2016 Apr 22. Radiother Oncol. 2016. PMID: 27118583
Intraoperative Neurovascular Bundle Preservation with Hyaluronic Acid during Radical Brachytherapy for Localized Prostate Cancer: Technique and MicroMosfet In Vivo Dosimetry.
Prada PJ, Ferri M, Cardenal J, Blanco AG, Arrojo E, Anchuelo J, de Cerio ID, Lastra P, Fernández A, Vázquez A, Arrebola SR. Prada PJ, et al. Among authors: blanco ag. Biomedicines. 2022 Apr 21;10(5):959. doi: 10.3390/biomedicines10050959. Biomedicines. 2022. PMID: 35625695 Free PMC article.
Anti-IL-6 Receptor Tocilizumab in Refractory Graves' Orbitopathy: National Multicenter Observational Study of 48 Patients.
Sánchez-Bilbao L, Martínez-López D, Revenga M, López-Vázquez Á, Valls-Pascual E, Atienza-Mateo B, Valls-Espinosa B, Maiz-Alonso O, Blanco A, Torre-Salaberri I, Rodríguez-Méndez V, García-Aparicio Á, Veroz-González R, Jovaní V, Peiteado D, Sánchez-Orgaz M, Tomero E, Toyos-Sáenz de Miera FJ, Pinillos V, Aurrecoechea E, Mora Á, Conesa A, Fernández-Prada M, Troyano JA, Calvo-Río V, Demetrio-Pablo R, González-Mazón Í, Hernández JL, Castañeda S, González-Gay MÁ, Blanco R. Sánchez-Bilbao L, et al. J Clin Med. 2020 Aug 31;9(9):2816. doi: 10.3390/jcm9092816. J Clin Med. 2020. PMID: 32878150 Free PMC article.
Biologic therapy in refractory neurobehçet's disease: a multicentre study of 41 patients and literature review.
Herrero-Morant A, Martín-Varillas JL, Castañeda S, Maíz O, Sánchez J, Ortego N, Raya E, Prior-Español Á, Moriano C, Melero-González RB, Graña-Gil J, Urruticoechea-Arana A, Ramos-Calvo Á, Loredo-Martínez M, Salgado-Pérez E, Sivera F, Torre I, Narváez J, Andreu JL, Martínez-González O, Torre RG, Fernández-Aguado S, Romero-Yuste S, González-Mazón Í, Álvarez-Reguera C, Hernández JL, González-Gay MÁ, Blanco R; Neurobehçet Spanish Collaborative Group. Herrero-Morant A, et al. Rheumatology (Oxford). 2022 Nov 2;61(11):4427-4436. doi: 10.1093/rheumatology/keac097. Rheumatology (Oxford). 2022. PMID: 35166821 Review.
Long-term Follow-up and Optimization of Infliximab in Refractory Uveitis Due to Behçet Disease: National Study of 103 White Patients.
Martín-Varillas JL, Atienza-Mateo B, Calvo-Rio V, Beltrán E, Sánchez-Bursón J, Adán A, Hernández-Garfella M, Valls-Pascual E, Sellas-Fernández A, Ortego N, Maíz O, Torre I, Fernández-Espartero C, Jovani V, Peiteado D, Valle DD, Aurrecoechea E, Caracuel MA, García-González AJ, Álvarez ER, Vegas-Revenga N, Demetrio-Pablo R, Castañeda S, González-Gay MA, Hernández JL, Blanco R; Ricardo Blanco on behalf of the Spanish Collaborative Group of Refractory Behçet’s Disease. Martín-Varillas JL, et al. J Rheumatol. 2021 May;48(5):741-750. doi: 10.3899/jrheum.200300. Epub 2020 Oct 1. J Rheumatol. 2021. PMID: 33004539
Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients.
Riancho-Zarrabeitia L, Calvo-Río V, Blanco R, Mesquida M, Adan AM, Herreras JM, Aparicio Á, Peiteado-Lopez D, Cordero-Coma M, García Serrano JL, Ortego-Centeno N, Maíz O, Blanco A, Sánchez-Bursón J, González-Suárez S, Fonollosa A, Santos-Gómez M, González-Vela C, Loricera J, Pina T, González-Gay MA. Riancho-Zarrabeitia L, et al. Semin Arthritis Rheum. 2015 Dec;45(3):361-8. doi: 10.1016/j.semarthrit.2015.05.010. Epub 2015 May 21. Semin Arthritis Rheum. 2015. PMID: 26092330
35 results